Cargando…
A Sensitive Assay System To Test Antisense Oligonucleotides for Splice Suppression Therapy in the Mouse Liver
We have previously demonstrated the efficacy of antisense therapy for splicing defects in cellular models of metabolic diseases, suppressing the use of cryptic splice sites or pseudoexon insertions. To date, no animal models with these defects are available. Here, we propose exon skipping of the phe...
Autores principales: | Gallego-Villar, Lorena, Viecelli, Hiu Man, Pérez, Belén, Harding, Cary O, Ugarte, Magdalena, Thöny, Beat, Desviat, Lourdes R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222650/ https://www.ncbi.nlm.nih.gov/pubmed/25226162 http://dx.doi.org/10.1038/mtna.2014.44 |
Ejemplares similares
-
Functional Characterization of the spf/ash Splicing Variation in OTC Deficiency of Mice and Man
por: Rivera-Barahona, Ana, et al.
Publicado: (2015) -
Correction: Functional Characterization of the spf/ash Splicing Variation in OTC Deficiency of Mice and Man
por: Rivera-Barahona, Ana, et al.
Publicado: (2015) -
Antisense Oligonucleotide Rescue of Deep-Intronic Variants Activating Pseudoexons in the 6-Pyruvoyl-Tetrahydropterin Synthase Gene
por: Martínez-Pizarro, Ainhoa, et al.
Publicado: (2022) -
Data in support of a functional analysis of splicing mutations in the IDS gene and the use of antisense oligonucleotides to exploit an alternative therapy for MPS II
por: Matos, Liliana, et al.
Publicado: (2015) -
Splice-switching antisense oligonucleotides as therapeutic drugs
por: Havens, Mallory A., et al.
Publicado: (2016)